Month: May 2019

2024.07.17
Summary of the most important events and achievements of the Genomtec S.A.

2024.06.25
Webinar: Trends in the M&A Market Specific to In-Vitro Diagnostics | 27 June, 2024, 3:00 p.m. (CEST)

2024.04.22
Dr. Trevor Hawkins, a distinguished entrepreneur, scientist, and leader with experience in global healthcare companies, has joined the Supervisory Board of Genomtec S.A.

2024.03.26
Genomtec secures PLN 10.6 million to fund scientific research and development of the oncology project - Company will raise capital from founding shareholders and investors

2024.03.26
Genomtec strengthens the Supervisory Board with individuals who bring extensive industry and business experience

Archive

2019.05.23

GENOMTEC is the winner of the Next Health Investment Pitch competition organized by Amgen and ImpactCEE

Warsaw, (23 May 2019) – Amgen and ImpactCEE announced the winner of the Next Health Investment Pitch. Genomtec, the creator of innovative ...
Read
2019.05.01

Smart Growth Operational Programme 2014-2020 – “Fast track”

The title of the project: Developing a portable diagnostic device based on lab-on-chip analysis system to detect COVID-19 disease (SARS-CoV-2 ...
Read

Archive